MAPT and Alzheimer disease: Another enzyme whose inhibition is likely to mediate the lithium neuroprotective effect is the glycogen synthase kinase-3 β (GSK-3β); the activity of this enzyme facilitates tau hyperphosphorylation and augments Aβ accumulation, playing a role in AD-related neurite dystrophy and neuronal death [200].